01 2Scemblix
Main Therapeutic Indication : Hematology
Currency : USD
2022 Revenue in Millions : 149
2021 Revenue in Millions : 7
Growth (%) : 2,029
Main Therapeutic Indication : Oncology
Currency : USD
2023 Revenue in Millions : 413
2022 Revenue in Millions : 149
Growth (%) : 177
LOOKING FOR A SUPPLIER?